Net profit of Epigral declined 62.26% to Rs 39.11 crore in the quarter ended December 2025 as against Rs 103.63 crore during the previous quarter ended December 2024. Sales declined 7.46% to Rs 597.12 crore in the quarter ended December 2025 as against Rs 645.24 crore during the previous quarter ended December 2024.
| Particulars | Quarter Ended | ||
| Dec. 2025 | Dec. 2024 | % Var. | |
| Sales | 597.12 | 645.24 | -7 |
| OPM % | 17.20 | 28.29 | - |
| PBDT | 97.31 | 186.53 | -48 |
| PBT | 54.56 | 153.62 | -64 |
| NP | 39.11 | 103.63 | -62 |
Powered by Capital Market - Live News